Oral PrEP must fill gap as Pepfar funding ends
The Namibian HIV Clinicians Society warns that the withdrawal of US President's Emergency Plan for AIDS Relief (Pepfar) funding by end-2027 threatens HIV prevention efforts, and advocates for wider access to oral PrEP (Truvada), which offers up to 99% efficacy in preventing HIV acquisition and is already available in Namibia, as the country has not yet rolled out the newer injectable form Lenacapavir.
27 September 2026 · The Namibian →